Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial.

Seebacher, V; Hofstetter, G; Polterauer, S; Reinthaller, A; Grimm, C; Schwameis, R; Taucher, S; Wagener, A; Marth, C; Concin, N

Seebacher, V; Hofstetter, G; Polterauer, S; Reinthaller, A; Grimm, C; Schwameis, R; Taucher, S; Wagener, A; Marth, C; Concin, N.

Afiliación

Seebacher V; Department of Gynaecology and Gynaecological Oncology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

Br J Cancer ; 109(1): 215-8, 2013 Jul 09.

Article en En | MEDLINE | ID: mdl-23764750

Asunto(s)

Neoplasias Endometriales/sangre; Neoplasias Endometriales/mortalidad; Tirotropina/sangre; Anciano; Neoplasias Endometriales/metabolismo; Femenino; Humanos; Estimación de Kaplan-Meier; Pronóstico; Glándula Tiroides/fisiología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tirotropina / Neoplasias Endometriales Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Br J Cancer Año: 2013 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google